US · Healthcare

Nascent Biotech Inc (NBIO)

Biotechnology

Nascent Biotech Inc (NBIO) is listed on US in the Healthcare sector. Industry: Biotechnology. As of 2026-03-24, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for NBIO

P/E ratio

18.00

Nascent Biotech Inc (NBIO) — FAQ

What is NBIO's P/E ratio?

The price-to-earnings (P/E) ratio for Nascent Biotech Inc (NBIO) is 18.00 (data as of 2026-03-24).

Does Nascent Biotech Inc pay a dividend?

Dividend yield is not available in the current snapshot for Nascent Biotech Inc (NBIO). Check the MyAverix Finance app for the latest dividend data.

What sector is Nascent Biotech Inc in?

Nascent Biotech Inc (NBIO) is classified in the Healthcare sector (Biotechnology industry).

What exchange is NBIO listed on?

NBIO is listed on US.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)